{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.05 vs. cons $1.99",
      "confidence": "HIGH"
    },
    {
      "kpi": "Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.96B vs. cons $1.97B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic order growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~+14% vs. implied street expectation ~+9-10%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$8.05-$8.25 (mid ~$8.15) vs. cons ~$8.08 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 revenue growth guidance",
      "prediction": "BETTER",
      "answer": "guide ~9% vs. cons ~8.3% high-single-digit (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Indicor deal timeline/pro forma leverage",
      "prediction": "UNCHANGED",
      "answer": "guide ~2.3x leverage at close, H2 2026 close vs. prior guide 2.3x, H2 2026 (Q3-Q4 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.8,
  "day5_path": "FADE",
  "day5_rationale": "Consensus is already parked near the top of AME's own Q2 guide ($1.96-2.00 EPS), leaving less room for the outsized beat-vs-guide margin (~3-4%) seen in prior quarters to translate into a similarly outsized beat-vs-Street; stock is also up ~12% into the print and near all-time highs with the average price target only ~8% above spot, limiting follow-through capacity. Historical analog quarters with moderate (not blow-out) beats (Q1'26, Q4'25) showed day-1 pops of ~2.3-2.4% fading to ~0.4-1.9% by day 5 as investors book gains and refocus on tougher H2 comps in Medical/EMG and the leverage/dilution overhang from the ~$5B Indicor deal (still pending regulatory close), which keeps out-period EPS revisions measured even after a headline beat-and-raise.",
  "day5_confidence": "MEDIUM"
}